Table 2.
CRE (mg/dL) | BUN (mg/dL) | TPR (mg/dL) | ||
---|---|---|---|---|
CONTROL | D 28 | 0.32 ± 0.07 | 23.94 ± 3.34 | 5.21 ± 0.15 |
D 14 | 0.34 ± 0.04 | 26.44 ± 4.59 | 4.78 ± 0.14 | |
AB 500 | D 28 | 0.28 ± 0.06 | 20.60 ± 1.45 | 4.87 ± 0.22 |
D 14 | 0.25 ± 0.05 | 18.20 ± 1.10 | 4.94 ± 0.08 | |
AB 250 | D 28 | 0.24 ± 0.05 | 17.54 ± 1.48 | 4.83 ± 0.21 |
D 14 | 0.22 ± 0.04 | 16.56 ± 2.15 | 4.36 ± 0.47 | |
AE 500 | D 28 | 0.44 ± 0.02 | 29.76 ± 1.23 | 5.69 ± 0.21 |
D 14 | 0.33 ± 0.08 | 26.32 ± 2.69 | 5.41 ± 0.35 | |
AE 250 | D 28 | 0.40 ± 0.02 | 28.66 ± 1.49 | 5.81 ± 0.29 |
D 14 | 0.28 ± 0.05 | 23.44 ± 1.06 | 4.98 ± 0.14 | |
AL 500 | D 28 | 0.58 ± 0.13* | 41.23 ± 5.18* | 6.79 ± 0.42* |
D 14 | 0.51 ± 0.02* | 39.23 ± 4.40* | 6.09 ± 0.19* | |
AL 250 | D 28 | 0.54 ± 0.05* | 40.09 ± 3.06* | 6.71 ± 0.56* |
D 14 | 0.49 ± 0.01* | 36.32 ± 2.66 | 5.97 ± 0.26* | |
CM 500 | D 28 | 0.40 ± 0.05 | 29.73 ± 6.94 | 6.11 ± 0.62 |
D 14 | 0.33 ± 0.01 | 25.34 ± 1.30 | 5.21 ± 0.15 | |
CM 250 | D 28 | 0.34 ± 0.02 | 28.51 ± 1.62 | 5.69 ± 0.21 |
D 14 | 0.28 ± 0.05 | 22.32 ± 4.83 | 4.96 ± 0.06 | |
CT 500 | D 28 | 0.54 ± 0.05* | 39.31 ± 5.98* | 6.61 ± 0.46* |
D 14 | 0.45 ± 0.03* | 35.34 ± 4.30 | 5.94 ± 0.28* | |
CT 250 | D 28 | 0.34 ± 0.01 | 23.48 ± 3.97 | 5.64 ± 0.53 |
D 14 | 0.28 ± 0.06 | 21.29 ± 2.16 | 4.93 ± 0.04 | |
EC 500 | D 28 | 0.57 ± 0.03* | 38.95 ± 4.59* | 6.56 ± 0.47* |
D 14 | 0.48 ± 0.01* | 34.62 ± 3.89 | 5.84 ± 0.41* | |
EC 250 | D 28 | 0.34 ± 0.02 | 28.48 ± 1.03 | 5.64 ± 0.53 |
D 14 | 0.28 ± 0.05 | 20.94 ± 3.34 | 4.93 ± 0.09 | |
PS 500 | D 28 | 0.39 ± 0.02 | 29.44 ± 1.06 | 5.75 ± 0.42 |
D 14 | 0.33 ± 0.02 | 24.57 ± 1.87 | 4.98 ± 0.26 | |
PS 250 | D 28 | 0.34 ± 0.01 | 28.48 ± 2.01 | 5.60 ± 0.45 |
D 14 | 0.24 ± 0.07 | 20.60 ± 1.55 | 4.87 ± 0.27 |
Values are expressed in mean ± SD (n = 6/group).
Significant difference with respect to control at p < 0.05.